undamentalytics Newsletter
Sign in

Apyx Medical Corp revenue

Apyx Medical Corp's revenue was $52.8m in fiscal 2025, up 9.9% on the year before. Since fiscal 2009 ($27.0m) it has grown at a compound 4.3% a year. Over the last twelve months it was $58.4m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue27242528242830910172828494552485358
Growth on the year before—−10.1%+4.9%+8.9%−14.5%+17.0%+6.6%−70.1%+16.0%+62.3%+70.0%−1.9%+75.1%−8.3%+17.6%−8.1%+9.9%—
Gross profit12101111991357111918342934293337

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Surgical Aesthetics $45.3M 85.8% ▲ 17.4%
Oem $7.5M 14.2% ▼ 20.9%
Geography
Region Revenue Share YoY
United States $38.8M 73.4% ▲ 14.0%
Outside the US $14M 26.6% ▼ 0.3%

From Apyx Medical Corp's 10-K filed March 10, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Apyx Medical Corp $58.4m 25.6% 7.2%
Lensar, Inc. $60.3m 3.3% 16.4%
Cvrx, Inc. $61.2m 12.0% 25.7%
Alpha PRO Tech LTD $61.9m 5.7% 2.9%
Iridex Corp $51.6m 3.7% -2.9%
Senseonics Holdings, Inc. $48.5m 90.6% 38.0%

Compare with peers

Head to head: APYX vs LNSRAPYX vs CVRXAPT vs APYXAPYX vs IRIX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Apyx Medical Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Apyx Medical Corp.